ARTICLE | Company News
Entest, Medistem deal
April 26, 2010 7:00 AM UTC
Entest announced it had signed a letter of intent to acquire about 61% of fellow stem cell company Medistem for $1 million in cash and $2 million in Entest shares. Thomas Ichim, CEO of Medistem, will ...